Castration Levels of Testosterone clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
Sorry, in progress, not accepting new patients
This phase II trial studies the how well apalutamide with or without stereotactic body radiation therapy work in treating participants with castration-resistant prostate cancer. Testosterone can cause the growth of prostate cancer cells. Hormone…
San Francisco, California
Our lead scientists for Castration Levels of Testosterone research studies include Rahul Aggarwal.
Last updated: